Medicinal cannabis was legalized in Germany in 2017. The regulatory framework to launch pharmaceuticals with cannabinoids is challenging. Producers and distributors have to navigate diligently to excel in the German market.
Suasionis has successfully launched various cannabinoid products for our clients. We understand the regulatory requirements and quickest pathways to market. EU member states have distinct national regulations that are not harmonized.
We tailor everything to your needs – from pharmaceutical quality systems to your operational set-up. Comply with regulations and cater for your business needs. We steer the processes to your market authorisation, permits and licenses.
Find below a short overview of the medical cannabis landscape in Germany. Many points apply to other European markets as well.